Publications 2019
The Role of Complement in Liver Injury, Regeneration, and Transplantation
70 (2), 725-736
DOI 10.1002/hep.30508, PubMed 30653682
Publications 2017
Properdin binding to complement activating surfaces depends on initial C3b deposition
114 (4), E534-E539
DOI 10.1073/pnas.1612385114, PubMed 28069958
Publications 2012
The role of properdin in zymosan- and Escherichia coli-induced complement activation
189 (5), 2606-13
DOI 10.4049/jimmunol.1200269, PubMed 22851705
Publications 2011
Advances in assay of complement function and activation
63 (12), 976-87
DOI 10.1016/j.addr.2011.05.010, PubMed 21664392
Publications 2010
Evidence for waning of latency in a cohort study of tuberculosis
10, 37
DOI 10.1186/1471-2334-10-37, PubMed 20178619
Publications 2009
Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian journal of immunology, turns 75
70 (6), 503-4
DOI 10.1111/j.1365-3083.2009.02343.x, PubMed 19906190
Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis
69 (6), 479-91
DOI 10.1111/j.1365-3083.2009.02255.x, PubMed 19439008
The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification
47 (2-3), 373-80
DOI 10.1016/j.molimm.2009.09.005, PubMed 19800125
Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies
78 (2), 802-9
DOI 10.1128/IAI.01044-09, PubMed 19933829
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature
106 (37), 15861-6
DOI 10.1073/pnas.0903613106, PubMed 19717455
Publications 2008
The alternative complement pathway revisited
12 (4), 1074-84
DOI 10.1111/j.1582-4934.2008.00350.x, PubMed 18419792
Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci
15 (5), 863-71
DOI 10.1128/CVI.00252-07, PubMed 18337382
Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood
46 (4), 688-94
DOI 10.1016/j.molimm.2008.09.001, PubMed 18950866
Publications 2007
A new type in the Gm system - Commentary
APMIS, 115 (5), 556-557
DOI 10.1111/j.1600-0463.2007.apm_688.x
Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7
14 (4), 451-63
DOI 10.1128/CVI.00008-07, PubMed 17301215
Publications 2006
[This is not our medical ethic]
126 (17), 2283
PubMed 16967071
[The new face of tuberculosis in Norway]
126 (20), 2682-3
PubMed 17057770
Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions
144 (3), 512-20
DOI 10.1111/j.1365-2249.2006.03072.x, PubMed 16734621
Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989
44 (3), 861-71
DOI 10.1128/JCM.44.3.861-871.2006, PubMed 16517868
Publications 2005
Challenges presented by nerve damage in leprosy
76 (1), 5-13
PubMed 15881032
Challenges presented by nerve damage in leprosy
Lepr. Rev., 76 (1), 5-13
Publications 2004
Female genital tuberculosis in Ethiopia
84 (3), 241-6
DOI 10.1016/j.ijgo.2003.11.002, PubMed 15001372
Female genital tuberculosis in Ethiopia
42 Suppl 1, 37-41
PubMed 16895018
T cell mediated immune responses in patients with tuberculous lymphadenitis from Butajira, southern Ethiopia
42 Suppl 1, 29-35
PubMed 16895017
Immunodominant B-cell epitope in the Mce1A mammalian cell entry protein of Mycobacterium tuberculosis cross-reacting with glutathione S-transferase
59 (2), 190-7
DOI 10.1111/j.0300-9475.2004.01383.x, PubMed 14871296
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
138 (3), 439-46
DOI 10.1111/j.1365-2249.2004.02627.x, PubMed 15544620
Publications 2003
Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia
131 (2), 841-8
DOI 10.1017/s0950268803001079, PubMed 14596524
Predicted molecular structure of the mammalian cell entry protein Mce1A of Mycobacterium tuberculosis
302 (3), 442-7
DOI 10.1016/s0006-291x(03)00116-5, PubMed 12615052
T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice
57 (2), 151-61
DOI 10.1046/j.1365-3083.2003.01211.x, PubMed 12588661
Diagnosis of tuberculous lymphadenitis in Butajira, rural Ethiopia
35 (4), 240-3
DOI 10.1080/00365540310004027, PubMed 12839151
Publications 2002
Cross-reaction between mammalian cell entry (Mce) proteins of Mycobacterium tuberculosis
56 (6), 580-7
DOI 10.1046/j.1365-3083.2002.01172.x, PubMed 12472669
Generation of antibodies to the signal peptide of the MPT83 lipoprotein of Mycobacterium tuberculosis
55 (1), 82-7
DOI 10.1046/j.1365-3083.2002.01030.x, PubMed 11841695
Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR
40 (11), 4230-4
DOI 10.1128/JCM.40.11.4230-4234.2002, PubMed 12409403
Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation
20 (27-28), 3370-8
DOI 10.1016/s0264-410x(02)00289-x, PubMed 12213407
Publications 2001
25th Kellersberger memorial lecture, 2000. The contribution of immunology to tuberculosis control
39 (1), 75-82
PubMed 11338470
[Immunology and control of tuberculosis]
121 (1), 88-91
PubMed 12013623
25(th) Kellersberger Memorial Lecture, 2000. The contribution of immunology to tuberculosis control
Ethiop. Med. J., 39 (1), 75-82
Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis
69 (9), 5936-9
DOI 10.1128/IAI.69.9.5936-5939.2001, PubMed 11500477
Novel monoclonal antibodies against major antigens of Mycobacterium bovis
53 (5), 498-502
DOI 10.1046/j.1365-3083.2001.00914.x, PubMed 11309158
High voltage direct current (HVDC) sea cables and sea electrodes: effects on marine life: 1st revision of the literature study
University of Oslo, Oslo, 50 s.
BIBSYS 070201072
Publications 2000
Leprosy at a turning point?
68 (3), 312-8
PubMed 11221095
Leprosy at a turning point?
Int. J. Lepr. Other Mycobact. Dis., 68 (3), 312-318
Robert N. Mshana, MD, Ph.D. 1954-2000 - Obituary
Int. J. Lepr. Other Mycobact. Dis., 68 (4), 475-476
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection
356 (9248), 2133-8
DOI 10.1016/s0140-6736(00)03493-0, PubMed 11191539
Clarification to Rada-Schlaefli, et al
68 (1), 63-4
PubMed 10834071
Clarification to Rada-Schlaefli, et al.
Int. J. Lepr. Other Mycobact. Dis., 68 (1), 63-64
Approaches to studying the transmission of Mycobacterium leprae
Lepr. Rev., 71 S, S26-S29
Publications 1999
Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis
50 (5), 510-8
DOI 10.1046/j.1365-3083.1999.00631.x, PubMed 10564554
Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis
Scand. J. Immunol., 50 (5), 510-518
Structure of the 15th International Leprosy Congress
Int. J. Lepr. Other Mycobact. Dis., 67 (1), 64-65
Demonstration of expression of six proteins of the mammalian cell entry (mce1) operon of Mycobacterium tuberculosis by anti-peptide antibodies, enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction
50 (5), 519-27
DOI 10.1046/j.1365-3083.1999.00632.x, PubMed 10564555
Demonstration of expression of six proteins of the mammalian cell entry (mce1) operon of Mycobacterium tuberculosis by anti-peptide antibodies, enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction
Scand. J. Immunol., 50 (5), 519-527
Searching for secreted proteins of Mycobacterium leprae
71 (1), 19-35
PubMed 10439323
Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis
26 (4), 207-19
DOI 10.1006/mpat.1998.0267, PubMed 10089161
The mammalian cell entry operon 1 (mce1) of mycobacterium leprae and mycobacterium tuberculosis
27 (3), 173-7
DOI 10.1006/mpat.1999.0298, PubMed 10455007
Publications 1998
Protective immunity to intracellular parasites--a focus for vaccine research and a challenge to immunization programmes
92, 145-7
PubMed 9554268
Protective immunity to intracellular parasites - A focus for vaccine research and a challenge to immunization programmes
Dev.Biol.Stand., 92, 145-147
Immunforsvaret hos eldre
In Medicinsk årbog, Norli, Oslo, 1998, s. 39-42
BIBSYS 050243713
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
66 (2), 717-23
DOI 10.1128/IAI.66.2.717-723.1998, PubMed 9453632
Secreted proteins of Mycobacterium leprae
48 (6), 577-84
DOI 10.1046/j.1365-3083.1998.00451.x, PubMed 9874491
Secreted proteins of Mycobacterium leprae
Scand. J. Immunol., 48 (6), 577-584
MPB70 and MPB83 as indicators of protein localization in mycobacterial cells
66 (1), 289-96
DOI 10.1128/IAI.66.1.289-296.1998, PubMed 9423870
Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis
5 (2), 211-8
DOI 10.1128/CDLI.5.2.211-218.1998, PubMed 9521145
In situ complement activation in porcine membranoproliferative glomerulonephritis type II
53 (2), 331-49
DOI 10.1046/j.1523-1755.1998.00765.x, PubMed 9461093
Erik Waaler - in memoriam
Scand. J. Rheumatol., 27 (2), 89-90
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients
30 (4), 363-9
DOI 10.1080/00365549850160657, PubMed 9817516
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients
Scand. J. Infect. Dis., 30 (4), 363-369
Immunochemical characterization of the MPB70/80 and MPB83 proteins of Mycobacterium bovis
66 (4), 1445-52
DOI 10.1128/IAI.66.4.1445-1452.1998, PubMed 9529066
Publications 1997
Eradication of porcine factor H deficiency in Norway
140 (15), 392-5
DOI 10.1136/vr.140.15.392, PubMed 9141221
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
Ann. Thorac. Surg., 63 (1), 105-111
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
63 (1), 105-11
DOI 10.1016/s0003-4975(96)00743-6, PubMed 8993250
Effect of whole and fractionated intravenous immunoglobulin on complement in vitro
34 (10), 719-29
DOI 10.1016/s0161-5890(97)00091-6, PubMed 9430199
Publications 1996
Helse og elektromagnetiske felt
In Medicinsk årbog, Norli, Oslo, 1996, s. 161-170
BIBSYS 042449499
European Commission COST/STD Initiative. Report of the expert panel IX. Vaccines against tuberculosis
14 (7), 701-16
DOI 10.1016/s0264-410x(96)90051-1, PubMed 8799982
European Commission COST/STD Initiative - Vaccines Against Tuberculosis
Vaccine, 14 (7), 701-716
Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
64 (1), 16-22
DOI 10.1128/iai.64.1.16-22.1996, PubMed 8557334
Low rates of detection of mycobacterial secretory antigen 85 in sera of untreated leprosy patients
64 (4), 451-3
PubMed 9030114
Low rates of detection of mycobacterial secretory antigen 85 in sera of untreated leprosy patients
Int. J. Lepr. Other Mycobact. Dis., 64 (4), 451-453
Clinical immunology
312 (7044), 1465-9
DOI 10.1136/bmj.312.7044.1465, PubMed 8664630
Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
43 (4), 374-80
DOI 10.1046/j.1365-3083.1996.d01-61.x, PubMed 8668915
Publications 1995
[Electromagnetic fields and health]
115 (20), 2522-3
PubMed 7676413
Taurin effluks fra isolerte rotteleverceller ved hyposmotiske betingelser
[M. Harboe], Oslo, 63 s.
BIBSYS 951762907
Homology between the MPB70 and MPB83 proteins of Mycobacterium bovis BCG
42 (1), 46-51
DOI 10.1111/j.1365-3083.1995.tb03624.x, PubMed 7631144
Molecular and immunological characterization of the highly conserved antigen 84 from Mycobacterium tuberculosis and Mycobacterium leprae
63 (3), 954-60
DOI 10.1128/iai.63.3.954-960.1995, PubMed 7868268
TERMINAL COMPLEMENT PATHWAY ACTIVATION AND LOW LYSIS INHIBITORS IN RHEUMATOID-ARTHRITIS SYNOVIAL-FLUID
J. Rheumatol., 22 (1), 24-28
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency
95 (3), 1054-61
DOI 10.1172/JCI117751, PubMed 7883953
Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid
22 (1), 24-8
PubMed 7535360
Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties
41 (5), 449-56
DOI 10.1111/j.1365-3083.1995.tb03591.x, PubMed 7725063
A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin
19 (9), 909-17
DOI 10.1111/j.1525-1594.1995.tb02450.x, PubMed 8687297
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell
41 (1), 42-8
DOI 10.1111/j.1365-3083.1995.tb03531.x, PubMed 7824887
Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination
63 (2), 672-5
DOI 10.1128/iai.63.2.672-675.1995, PubMed 7822037
Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis
63 (12), 4946-8
DOI 10.1128/iai.63.12.4946-4948.1995, PubMed 7591163
Publications 1994
Dual role of mannan-binding protein in infections: another case of heterosis?
21 (2), 125-31
DOI 10.1111/j.1744-313x.1994.tb00183.x, PubMed 9098426
Faglig utvalg til vurdering av mulig helsefare knyttet til lavfrekvente elektromagnetiske felt: redegjørelse for utvalgets arbeid og rapporten til Sosial- og helsedepartementet ved presseseminaret 18. mai 1994
Utvalget, Oslo, 6 s.
BIBSYS 000269239
Differential effects of cyclic adenosine 3',5'-monophosphate on T cell cytotoxicity
24 (9), 2150-4
DOI 10.1002/eji.1830240932, PubMed 8088333
Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area
35 (3), 382-7
DOI 10.1136/gut.35.3.382, PubMed 8150352
Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours
69 (6), 1078-82
DOI 10.1038/bjc.1994.211, PubMed 8198973
Characterization of a Mycobacterium leprae antigen related to the secreted Mycobacterium tuberculosis protein MPT32
62 (1), 252-8
DOI 10.1128/iai.62.1.252-258.1994, PubMed 8262636
Publications 1993
Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG
61 (6), 2687-93
DOI 10.1128/iai.61.6.2687-2693.1993, PubMed 8500908
Quantitation of vitronectin and clusterin. Pitfalls and solutions in enzyme immunoassays for adhesive proteins
160 (1), 107-15
DOI 10.1016/0022-1759(93)90014-x, PubMed 7680696
Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG
61 (5), 1730-4
DOI 10.1128/iai.61.5.1730-1734.1993, PubMed 8478061
Anti-gammaglobulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies. Vox Sang 1963;8:133-52
64 (4), 246-7
DOI 10.1111/j.1423-0410.1993.tb03065.x, PubMed 7685972
The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues
61 (5), 1835-45
DOI 10.1128/iai.61.5.1835-1845.1993, PubMed 7682995
Identification of a novel 27-kDa protein from Mycobacterium tuberculosis culture fluid by a monoclonal antibody specific for the Mycobacterium tuberculosis complex
37 (4), 471-8
DOI 10.1111/j.1365-3083.1993.tb03321.x, PubMed 8469931
Publications 1992
The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases
60 (3), 470-6
PubMed 1474286
[Gerhard Henrik Armauer Hansen--still of current interest]
112 (30), 3795-8
PubMed 1485294
THE SIGNIFICANCE OF PROTEINS ACTIVELY SECRETED BY MYCOBACTERIUM-TUBERCULOSIS IN RELATION TO IMMUNITY AND COMPLICATIONS OF MYCOBACTERIAL DISEASES
Int. J. Lepr. Other Mycobact. Dis., 60 (3), 470-476
The 38-kDa protein of Mycobacterium tuberculosis: a review
166 (4), 874-84
DOI 10.1093/infdis/166.4.874, PubMed 1527425
Protein antigens of mycobacteria studied by quantitative immunologic techniques
14 (1), 313-9
DOI 10.1093/clinids/14.1.313, PubMed 1571446
HEPARIN-BINDING PROPERTIES OF VITRONECTIN ARE LINKED TO COMPLEX-FORMATION AS ILLUSTRATED BY INVITRO POLYMERIZATION AND BINDING TO THE TERMINAL COMPLEMENT COMPLEX
J. Biol. Chem., 267 (32), 23076-23082
Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex
267 (32), 23076-82
PubMed 1385412
Identification and characterization of epitopes shared between the mycobacterial 65-kilodalton heat shock protein and the actively secreted antigen 85 complex: their in situ expression on the cell wall surface of Mycobacterium leprae
60 (11), 4517-27
DOI 10.1128/iai.60.11.4517-4527.1992, PubMed 1383151
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface
60 (12), 5172-81
DOI 10.1128/iai.60.12.5172-5181.1992, PubMed 1280626
Does graft-violates-host disease give a better indication of what goes on than graft-versus-host disease?
232 (4), 372
PubMed 1402643
DOES GRAFT-VIOLATES-HOST DISEASE GIVE A BETTER INDICATION OF WHAT GOES ON THAN GRAFT-VERSUS-HOST DISEASE
J. Intern. Med., 232 (4), 372
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis
56 (4), 648-61
DOI 10.1128/mr.56.4.648-661.1992, PubMed 1480113
THE ANTIGEN-85 COMPLEX - A MAJOR SECRETION PRODUCT OF MYCOBACTERIUM-TUBERCULOSIS
Microbiol. Rev., 56 (4), 648-661
DOI 10.1128/MMBR.56.4.648-661.1992
A family of cross-reacting proteins secreted by Mycobacterium tuberculosis
36 (2), 307-19
DOI 10.1111/j.1365-3083.1992.tb03104.x, PubMed 1502498
Publications 1991
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins
59 (8), 2712-8
DOI 10.1128/iai.59.8.2712-2718.1991, PubMed 1830294
Heat shock proteins: friend and foe?
86 (1), 2-5
DOI 10.1111/j.1365-2249.1991.tb05764.x, PubMed 1914233
HEAT-SHOCK PROTEINS - FRIEND AND FOE
Clin. Exp. Immunol., 86 (1), 2-5
Interpreting complicated chromatographic patterns
9 (8), 663-9
DOI 10.1016/0731-7085(91)80193-d, PubMed 1790187
Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin
52 (1), 92-7
DOI 10.1016/0003-4975(91)91426-v, PubMed 2069469
Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials
86 Suppl 1 (Suppl 1), 21-6
PubMed 1934602
Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis
59 (1), 372-82
DOI 10.1128/iai.59.1.372-382.1991, PubMed 1898899
C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis
20 (3), 183-9
DOI 10.3109/03009749109103019, PubMed 2068540
C-3 ACTIVATION PRODUCTS, C-3 CONTAINING IMMUNE-COMPLEXES, THE TERMINAL COMPLEMENT COMPLEX AND NATIVE C-9 IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Scand. J. Rheumatol., 20 (3), 183-189
Purification and characterization of the 30,000 dalton native antigen of Mycobacterium tuberculosis and characterization of six monoclonal antibodies reactive with a major epitope of this antigen
118 (6), 589-98
PubMed 1720803
PURIFICATION AND CHARACTERIZATION OF THE 30,000 DALTON NATIVE ANTIGEN OF MYCOBACTERIUM-TUBERCULOSIS AND CHARACTERIZATION OF 6 MONOCLONAL-ANTIBODIES REACTIVE WITH A MAJOR EPITOPE OF THIS ANTIGEN
J. Lab. Clin. Med., 118 (6), 589-598
A localization index for distinction between extracellular and intracellular antigens of Mycobacterium tuberculosis
137 (4), 875-84
DOI 10.1099/00221287-137-4-875, PubMed 1906925
Publications 1990
Latex gloves as a cause of inflammation and eczema
335 (8703), 1469
DOI 10.1016/0140-6736(90)91502-2, PubMed 1972244
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (3. utg., rev.), 349 s.
BIBSYS 90078220x, ISBN 82-90225-04-0
Protein G-based enzyme-linked immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis
28 (5), 913-21
DOI 10.1128/jcm.28.5.913-921.1990, PubMed 2191012
Carrier effect of concanavalin A-reactive and -non-reactive material in tuberculin PPD
32 (3), 263-71
DOI 10.1111/j.1365-3083.1990.tb02919.x, PubMed 2402595
Integration of monoclonal antibodies in quantitative immunoelectrophoresis by indirect immunoprecipitation
132 (1), 127-35
DOI 10.1016/0022-1759(90)90406-l, PubMed 2202762
Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG
141 (4 Pt 1), 830-8
DOI 10.1164/ajrccm/141.4_Pt_1.830, PubMed 2109556
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex
58 (1), 272-4
DOI 10.1128/iai.58.1.272-274.1990, PubMed 2403534
Publications 1989
[Norwegian nomenclature in immunology]
109 (7-8), 853-5
PubMed 2705171
Publications 1988
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG
56 (12), 3046-51
DOI 10.1128/iai.56.12.3046-3051.1988, PubMed 3141278
INVITRO SYNTHESIS OF ANTIMYCOBACTERIAL ANTIBODIES WITH DIFFERENT SPECIFICITIES IN VARIOUS TISSUES OF LEPROSY PATIENTS
Int. J. Lepr. Other Mycobact. Dis., 56 (4), 552-558
Rheumatoid factors in leprosy and parasitic diseases
75, 309-13
DOI 10.3109/03009748809096783, PubMed 3070728
In vitro synthesis of antimycobacterial antibodies with different specificities in various tissues of leprosy patients
56 (4), 552-8
PubMed 3065420
The antigens of Mycobacterium tuberculosis, H37Rv, studied by crossed immunoelectrophoresis. Comparison with a reference system for Mycobacterium bovis, BCG
27 (2), 223-39
DOI 10.1111/j.1365-3083.1988.tb02342.x, PubMed 3124264
Publications 1987
Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70
55 (12), 3213-4
DOI 10.1128/iai.55.12.3213-3214.1987, PubMed 3316036
Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG
55 (1), 245-52
DOI 10.1128/iai.55.1.245-252.1987, PubMed 3539805
Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG
2 (5), 351-66
DOI 10.1016/0882-4010(87)90077-5, PubMed 3148811
Analysis of monoclonal antibodies to Mycobacterium leprae by crossed immunoelectrophoresis
25 (2), 133-8
DOI 10.1111/j.1365-3083.1987.tb01056.x, PubMed 3547616
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (3. utg.), 347 s.
BIBSYS 875020003, ISBN 87-7437-085-5
Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy
55 (4), 617-25
PubMed 3323365
ANTIBODIES TO A SYNTHETIC ANALOG OF PHENOLIC GLYCOLIPID-I OF MYCOBACTERIUM-LEPRAE IN HEALTHY HOUSEHOLD CONTACTS OF PATIENTS WITH LEPROSY
Int. J. Lepr. Other Mycobact. Dis., 55 (4), 617-625
Immunohistochemical detection of the membrane and fluid-phase terminal complement complexes C5b-9(m) and SC5b-9. Consequences for interpretation and terminology
26 (4), 381-6
DOI 10.1111/j.1365-3083.1987.tb02270.x, PubMed 3685888
Comparison of antigens and antisera in crossed immunoelectrophoresis by dual dilution
97 (2), 201-7
DOI 10.1016/0022-1759(87)90460-1, PubMed 3102615
Publications 1986
Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae
57 Suppl 2, 293-300
PubMed 3553802
Functions of an external medical advisory committee
57 Suppl 1, 41-6
PubMed 3586834
Functions of an external medical advisory committee
24 Suppl 1, 41-6
PubMed 3608999
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG
52 (1), 293-302
DOI 10.1128/iai.52.1.293-302.1986, PubMed 3514457
Immunological and biochemical characterization and classification of mycobacterial antigens
57 Suppl 2, 33-7
DOI 10.5935/0305-7518.19860052, PubMed 3573945
Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex
29 (6), 715-21
DOI 10.1002/art.1780290603, PubMed 3718564
Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro
65 (1), 73-9
PubMed 3641694
EFFECT OF NEPHRITIC FACTOR ON C-3 AND ON THE TERMINAL PATHWAY OF COMPLEMENT INVIVO AND INVITRO
Clin. Exp. Immunol., 65 (1), 73-79
MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo
58 ( Pt B), 511-6
PubMed 3301461
ANTIGENS OF MYCOBACTERIUM-LEPRAE IN URINE DURING TREATMENT OF PATIENTS WITH LEPROMATOUS LEPROSY
Lepr. Rev., 57 (4), 329-340
Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy
57 (4), 329-40
PubMed 3540495
Purification and characterization of two protein antigens from the heterogeneous BCG85 complex in Mycobacterium bovis BCG
81 (4), 298-306
DOI 10.1159/000234153, PubMed 3536755
MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG
81 (4), 307-14
DOI 10.1159/000234154, PubMed 3536756
Publications 1985
Cross-reactivity of antigens from the cytoplasm and cell walls of some corynebacteria and mycobacteria
151 (1), 170-8
DOI 10.1093/infdis/151.1.170, PubMed 3965589
Cell markers in stored blood
16 (6), 393-7
DOI 10.1016/0020-1383(85)90054-3, PubMed 4008032
Characterization of the specificity of monoclonal antibodies against Mycobacterium tuberculosis by crossed immunoelectrophoresis
22 (1), 93-8
DOI 10.1111/j.1365-3083.1985.tb01863.x, PubMed 3927476
LEPROSY IN A MANGABEY MONKEY NATURALLY ACQUIRED INFECTION
Int. J. Lepr. Other Mycobact. Dis., 53 (1), 1-14
Increased plasma levels of the terminal complement complex in patients with evidence of complement activation
2 (2-3), 175-84
DOI 10.1159/000467858, PubMed 3878765
Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex
22 (2), 197-202
DOI 10.1111/j.1365-3083.1985.tb01871.x, PubMed 2412280
Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma
22 (2), 183-95
DOI 10.1111/j.1365-3083.1985.tb01870.x, PubMed 4035298
Characterization of the immune response to an epitope on Mycobacterium leprae antigen 7 defined by a monoclonal antibody
22 (6), 711-20
DOI 10.1111/j.1365-3083.1985.tb01934.x, PubMed 2418496
Publications 1984
MPB70, a unique antigen of Mycobacterium bovis BCG
129 (3), 444-52
DOI 10.1164/arrd.1984.129.3.444, PubMed 6367574
MPB70, A UNIQUE ANTIGEN OF MYCOBACTERIUM-BOVIS BCG
Am. Rev. Respir. Dis., 129 (3), 444-452
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (2. rev. utg.), 322 s.
BIBSYS 842153586, ISBN 82-90225-02-4
Experimental leprosy in nonhuman primates
28, 201-36
DOI 10.1016/b978-0-12-039228-5.50012-7, PubMed 6441464
EXPERIMENTAL LEPROSY IN NONHUMAN-PRIMATES
Adv. Vet. Sci. Comp. Med., 28, 201-236
Detection and quantification of the terminal C5b-9 complex of human complement by a sensitive enzyme-linked immunosorbent assay
20 (2), 157-66
DOI 10.1111/j.1365-3083.1984.tb00989.x, PubMed 6474098
Anti-Mycobacterium leprae antibodies in urine from lepromatous patients examined by crossed immunoelectrophoresis and radioimmunoassay
19 (6), 521-8
DOI 10.1111/j.1365-3083.1984.tb00963.x, PubMed 6377478
Immunochemical studies on human monoclonal macroglobulins with specificities for 3,4-pyruvylated D-galactose and 4,6-pyruvylated D-glucose
259 (2), 1018-26
PubMed 6693372
IMMUNOCHEMICAL STUDIES ON HUMAN MONOCLONAL MACROGLOBULINS WITH SPECIFICITIES FOR 3,4-PYRUVYLATED D-GALACTOSE AND 4,6-PYRUVYLATED D-GLUCOSE
J. Biol. Chem., 259 (2), 1018-1026
Publications 1983
Effect of treatment on antibody activity against Mycobacterium leprae antigen 7 in tuberculoid leprosy
51 (3), 312-20
PubMed 6358062
EFFECT OF TREATMENT ON ANTIBODY-ACTIVITY AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 IN TUBERCULOID LEPROSY
Int. J. Lepr. Other Mycobact. Dis., 51 (3), 312-320
Comparison of the cytoplasmic antigens of leprosy-derived corynebacteria and some mycobacteria
17 (6), 497-506
DOI 10.1111/j.1365-3083.1983.tb00817.x, PubMed 6191381
The work and concepts of Armauer Hansen: how do they stand today?
21 (2), 123-6
PubMed 6343074
THE WORK AND CONCEPTS OF HANSEN,ARMAUER - HOW DO THEY STAND TODAY
Ethiop. Med. J., 21 (2), 123-126
RELATION BETWEEN ANTI-MYCOBACTERIUM-LEPRAE ANTIBODY-ACTIVITY AND CLINICAL-FEATURES IN BORDERLINE TUBERCULOID (BT) LEPROSY
Int. J. Lepr. Other Mycobact. Dis., 51 (3), 305-311
Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein
51 (1), 33-40
PubMed 6190769
IMMUNE-RESPONSES TO BOVINE NEURAL ANTIGENS IN LEPROSY PATIENTS .1. ABSENCE OF ANTIBODIES TO AN ISOLATED MYELIN PROTEIN
Int. J. Lepr. Other Mycobact. Dis., 51 (1), 33-40
Immunohistological studies of skin biopsies from patients with lepromatous leprosy
3 (1), 22-9
DOI 10.1007/BF00919135, PubMed 6338025
Immune responses to bovine neural antigens in leprosy patients. II. Absence of in vitro lymphocyte stimulation to peripheral nerve myelin proteins
54 (3), 217-27
DOI 10.5935/0305-7518.19830029, PubMed 6195500
Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria
52 (2), 441-8
PubMed 6345041
Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique
29 (3), 359-68
DOI 10.1016/0090-1229(83)90039-9, PubMed 6416726
NERVE DAMAGE FOLLOWING INTRANEURAL INJECTION OF MYCOBACTERIUM-LEPRAE INTO RABBITS PRESENSITIZED TO MYCOBACTERIA
Clin. Exp. Immunol., 52 (2), 441-448
IMMUNE-RESPONSES TO BOVINE NEURAL ANTIGENS IN LEPROSY PATIENTS .2. ABSENCE OF INVITRO LYMPHOCYTE STIMULATION TO PERIPHERAL-NERVE MYELIN PROTEINS
Lepr. Rev., 54 (3), 217-227
Antigens of Mycobacterium leprae and anti-M. leprae antibodies in the urine of leprosy patients
54 (3), 203-16
DOI 10.5935/0305-7518.19830028, PubMed 6355725
ANTIGENS OF MYCOBACTERIUM-LEPRAE AND ANTI-MYCOBACTERIUM-LEPRAE ANTIBODIES IN THE URINE OF LEPROSY PATIENTS
Lepr. Rev., 54 (3), 203-216
Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy
51 (3), 305-11
PubMed 6358061
Publications 1982
Fatty acid and polar lipid analysis as tools in the identification of Mycobacterium leprae and some related slow-growing mycobacterial species
133 (1), 29-37
PubMed 7051927
FATTY-ACID AND POLAR LIPID ANALYSIS AS TOOLS IN THE IDENTIFICATION OF MYCOBACTERIUM-LEPRAE AND SOME RELATED SLOW-GROWING MYCOBACTERIAL SPECIES
ANN INST PASTEUR MIC, B133 (1), 29-37
In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative
16 (2), 103-15
DOI 10.1111/j.1365-3083.1982.tb00704.x, PubMed 6182610
Significance of antibody studies in leprosy and experimental models of the disease
50 (3), 342-50
PubMed 6754640
SIGNIFICANCE OF ANTIBODY STUDIES IN LEPROSY AND EXPERIMENTAL-MODELS OF THE DISEASE
Int. J. Lepr. Other Mycobact. Dis., 50 (3), 342-350
Medisinsk immunologi
Stiftelsen medisinsk immunologi, [Oslo] (2. utg.), 311 s.
BIBSYS 835001067, ISBN 82-90225-01-6
IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life
49 (3), 532-42
PubMed 6756719
IGA, IGM AND IGG ANTI-M-LEPRAE ANTIBODIES IN BABIES OF LEPROSY MOTHERS DURING THE 1ST 2 YEARS OF LIFE
Clin. Exp. Immunol., 49 (3), 532-542
Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy
47 (2), 225-33
PubMed 7042137
IMMUNOGLOBULIN CLASS SPECIFIC ANTIBODIES TO M- LEPRAE IN LEPROSY PATIENTS, INCLUDING THE INDETERMINATE GROUP AND HEALTHY CONTACTS AS A STEP IN THE DEVELOPMENT OF METHODS FOR SERO-DIAGNOSIS OF LEPROSY
Clin. Exp. Immunol., 47 (2), 225-233
Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment
50 (3), 271-81
PubMed 6754639
CLASS SPECIFIC ANTI-MYCOBACTERIUM LEPRAE ANTIBODY-ASSAY IN LEPROMATOUS LEPROSY (BL-LL) PATIENTS DURING THE 1ST 2 TO 4 YEARS OF DDS TREATMENT
Int. J. Lepr. Other Mycobact. Dis., 50 (3), 271-281
Demonstration of mycobacterial antigens in leprosy tissues
50 (1), 1-10
PubMed 7042609
DEMONSTRATION OF MYCOBACTERIAL ANTIGENS IN LEPROSY TISSUES
Int. J. Lepr. Other Mycobact. Dis., 50 (1), 1-10
Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies
50 (3), 291-6
PubMed 6216220
THYMUS DEPENDENT LYMPHOCYTES IN LEPROSY .1. LYMPHOCYTE-T SUB-POPULATIONS DEFINED BY MONOCLONAL-ANTIBODIES
Int. J. Lepr. Other Mycobact. Dis., 50 (3), 291-296
Publications 1981
Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis
124 (1), 80-7
DOI 10.1164/arrd.1981.124.1.80, PubMed 7020505
Mycobacterium leprae and the host response
52 Suppl 1, 1-14
PubMed 7040872
Radioimmunoassay and other serologic tests and their application in epidemiological work
52 Suppl 1, 275-88
DOI 10.5935/0305-7518.19810077, PubMed 7040881
ANTIGENS OF PPD, OLD TUBERCULIN, AND AUTOCLAVED MYCOBACTERIUM-BOVIS BCG STUDIED BY CROSSED IMMUNOELECTROPHORESIS
Am. Rev. Respir. Dis., 124 (1), 80-87
MYCOBACTERIUM-LEPRAE AND THE HOST RESPONSE
Lepr. Rev., 52 1, 1-14
RADIOIMMUNOASSAY AND OTHER SEROLOGIC TESTS AND THEIR APPLICATION IN EPIDEMIOLOGICAL WORK
Lepr. Rev., 52 1, 275-288
A claim for a Mycobacterium leprae specific antigen
49 (1), 85-9
PubMed 6788723
A CLAIM FOR A MYCOBACTERIUM-LEPRAE SPECIFIC ANTIGEN
Int. J. Lepr. Other Mycobact. Dis., 49 (1), 86-88
Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7
49 (2), 147-58
PubMed 6168595
DEMONSTRATION OF ANTIBODIES REACTING WITH DIFFERENT DETERMINANTS ON MYCOBACTERIUM-LEPRAE ANTIGEN-7
Int. J. Lepr. Other Mycobact. Dis., 49 (2), 147-158
IgA and IgM antibodies against Mycobacterium leprae in cord sera and in patients with leprosy: an indicator of intrauterine infection in leprosy
14 (4), 343-52
DOI 10.1111/j.1365-3083.1981.tb00574.x, PubMed 7038849
Publications 1980
The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system
12 (3), 249-63
DOI 10.1111/j.1365-3083.1980.tb00065.x, PubMed 7008186
Structural studies of three IgG kappa proteins from a patient with multiple myeloma
12 (4), 281-7
DOI 10.1111/j.1365-3083.1980.tb00068.x, PubMed 6781064
Immunological aspects of leprosy: ten years' activity at the Armauer Hansen Research Institute and Prospects for further work
48 (2), 193-205
PubMed 6156919
Anders Jahre's medical prizes for 1980 (Björn Folkow, Fredrik Kiil, Jens F Rehfeld, Lars Terenius)
30 (11-12), 137-43
PubMed 7012283
In vitro synthesis of anti-mycobacterial antibodies in biopsies from skin lesions of leprosy patients
27 (2), 297-301
DOI 10.1128/iai.27.2.297-301.1980, PubMed 6991410
Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy
42 (1), 107-13
PubMed 7006873
ANTIBODIES AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 FROM BIRTH TO 18 MONTHS OF AGE - AN INDICATOR OF INTRAUTERINE INFECTION IN LEPROSY
Clin. Exp. Immunol., 42 (1), 107-113
COMPARATIVE STUDIES OF ANTIGEN-21 IN MYCOBACTERIUM AND NOCARDIA SPECIES - POSSIBLE TAXONOMIC RELATIONSHIPS WITH MYCOBACTERIUM-LEPRAE
Infect. Immun., 30 (2), 413-420
Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae
30 (2), 413-20
DOI 10.1128/iai.30.2.413-420.1980, PubMed 7002798
Publications 1979
Antigenic analysis of Mycobacterium leprae
9 (3), 297-302
DOI 10.1111/j.1365-3083.1979.tb02735.x, PubMed 373076
Albert Coons, 1912--78
9 (5), 395-6
DOI 10.1111/j.1365-3083.1979.tb03179.x, PubMed 379980
[Nil nocere]
99 (1), 2-3
PubMed 760236
Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria
9 (2), 115-24
DOI 10.1111/j.1365-3083.1979.tb02713.x, PubMed 106465
Antibody response in rabbits to Mycobacterium bovis BCG
9 (2), 175-82
DOI 10.1111/j.1365-3083.1979.tb02720.x, PubMed 370972
Cross-reactions between serum proteins and water soluble liver tissue antigens of the nine-banded armadillo (Dasypus novemcinctus Linn.) and man
38 (1), 135-47
PubMed 93527
CROSS-REACTIONS BETWEEN SERUM-PROTEINS AND WATER-SOLUBLE LIVER-TISSUE ANTIGENS OF THE 9-BANDED ARMADILLO (DASYPUS-NOVEMCINCTUS LINN) AND MAN
Clin. Exp. Immunol., 38 (1), 135-147
Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy
50 (2), 113-21
DOI 10.5935/0305-7518.19790017, PubMed 396427
ANTIBODY-ACTIVITY AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 IN LEPROSY - STUDIES ON VARIATION IN ANTIBODY CONTENT THROUGHOUT THE SPECTRUM AND ON THE EFFECT OF DDS TREATMENT AND RELAPSE IN BT-LEPROSY
Lepr. Rev., 50 (2), 113-121
Publications 1978
Mycobacterium leprae specific antibodies detected by radioimmunoassay
7 (2), 111-20
DOI 10.1111/j.1365-3083.1978.tb00433.x, PubMed 77549
Formation of antibody against Mycobacterium leprae antigen 7 in armadillos
11 (4), 525-35
DOI 10.1099/00222615-11-4-525, PubMed 364069
Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy
49 (1), 17-29
PubMed 347205
ANTIBODY ACTIVITY AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 DURING 1ST YEAR OF DDS TREATMENT IN LEPROMATOUS (BL-LL) LEPROSY
Lepr. Rev., 49 (1), 17-29
False spurs in quantitative immunoelectrophoresis
8 (4), 279-90
DOI 10.1111/j.1365-3083.1978.tb00521.x, PubMed 82271
Characterization of lymphocytes isolated from non-lymphoid human malignant tumours
7 (6), 487-93
DOI 10.1111/j.1365-3083.1978.tb00482.x, PubMed 356179
Publications 1977
Antibodies against BCG antigen 60 in mycobacterial infection
2 (6084), 430-3
DOI 10.1136/bmj.2.6084.430, PubMed 407965
Antibody response in rabbits to immunization with Mycobacterium leprae
18 (3), 792-805
DOI 10.1128/iai.18.3.792-805.1977, PubMed 338491
Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG
16 (2), 662-72
DOI 10.1128/iai.16.2.662-672.1977, PubMed 324917
Publications 1976
MU-CHAIN DISEASE IN A CASE OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MALIGNANT HISTIOCYTOMA .2. IMMUNOCHEMICAL STUDIES
SCAND J HAEMATOL, 16 (3), 218-225
Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies
16 (3), 218-25
DOI 10.1111/j.1600-0609.1976.tb01141.x, PubMed 179131
Importance of immune reactions in leprosy
14 (4), 205-12
PubMed 799966
Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG)
5 (6-7), 861-6
DOI 10.1111/j.1365-3083.1976.tb03035.x, PubMed 790542
Sudden death caused by interaction between a macroglobulin and a divalent drug
2 (7980), 285-9
DOI 10.1016/s0140-6736(76)90734-0, PubMed 59856
SUDDEN-DEATH CAUSED BY INTERACTION BETWEEN A MACROGLOBULIN AND A DIVALENT DRUG
Lancet, 2 (7980), 285-288
MU-CHAIN DISEASE IN A CASE OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MALIGNANT HISTIOCYTOMA .1. CLINICAL ASPECTS
SCAND J HAEMATOL, 16 (3), 209-217
mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects
16 (3), 209-17
DOI 10.1111/j.1600-0609.1976.tb01140.x, PubMed 179130
Binding of IgA to protein-A-containing staphylococci: relationship to subclasses
5 (10), 1103-8
DOI 10.1111/j.1365-3083.1976.tb00250.x, PubMed 1013646
BINDING OF IGA TO PROTEIN-A-CONTAINING STAPHYLOCOCCI - RELATIONSHIP TO SUBCLASSES
Scand. J. Immunol., 5 (10), 1103-1108
Publications 1975
CROSS-REACTIONS BETWEEN MYCOBACTERIA .1. CROSSED IMMUNOELECTROPHORESIS OF SOLUBLE-ANTIGENS OF MYCOBACTERIUM-LEPRAEMURIUM AND COMPARISON WITH BCG
Scand. J. Immunol. (2), 173-185
MONOCLONAL IGM WITH SPECIFIC ANTIBODY REACTIVITY AGAINST KLEBSIELLA SERO-TYPES 12 AND 13
ACTA PATH MICRO IM C, 83 (2), 106-111
Common idiotypic antigenic determinants on monomeric (7S) and polymeric IgM from the same serum
4 (5-6), 583-90
DOI 10.1111/j.1365-3083.1975.tb02664.x, PubMed 52185
CAPSULAR SWELLING AND PASSIVE HEMAGGLUTINATION INDUCED BY MONOCLONAL IGM REACTING WITH ACID POLYSACCHARIDES OF KLEBSIELLA
ACTA PATH MICRO IM C, 83 (2), 97-105
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo, 257 s.
BIBSYS 741136406, ISBN 82-90225-00-8
Medisinsk immunologi
Universitetsforlaget, Oslo, 257 s.
BIBSYS 855005181, ISBN 82-00-02362-1
INTERACTIONS BETWEEN RICINUS AGGLUTININ AND HUMAN PLASMA-PROTEINS
Scand. J. Immunol. (2), 125-134
Protein A reactivity of two distinct groups of human monoclonal IgM
4 (8), 843-8
DOI 10.1111/j.1365-3083.1975.tb03726.x, PubMed 1215839
PROTEIN-A REACTIVITY OF 2 DISTINCT GROUPS OF HUMAN MONOCLONAL-IGM
Scand. J. Immunol., 4 (8), 843-848
DOI 10.1111/j.1365-3083.1975.tb02695.x
Interactions between ricinus agglutinin and human IgM and IgG
4 (3), 287-94
DOI 10.1111/j.1365-3083.1975.tb02628.x, PubMed 1080291
Publications 1974
BCG antibody profiles in tuberculoid and lepromatous leprosy
9 (5), 952-8
DOI 10.1128/iai.9.5.952-958.1974, PubMed 4207518
[Immunological aspects of acquired hemolytic anemia]
94 (5), 312-5
PubMed 4544871
[The immunologists take a look at cell membrane]
94 (19), 1271-2
PubMed 4845302
The activation of bovine pepsinogen. Sequence of the peptides released, identification of a pepsin inhibitor
249 (14), 4487-94
PubMed 4603017
Complex formation between monoclonal IgM and albumin
3 (1), 51-60
DOI 10.1111/j.1365-3083.1974.tb01232.x, PubMed 4208200
Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci
3 (4), 471-82
DOI 10.1111/j.1365-3083.1974.tb01280.x, PubMed 4212304
The occurrence in sera with m-components of different proteins related to amyloid fibrils
3 (4), 391-6
DOI 10.1111/j.1365-3083.1974.tb01271.x, PubMed 4212436
On the frequency of valine in position 2 of the V k3 subgroup
3 (2), 215-8
DOI 10.1111/j.1365-3083.1974.tb01250.x, PubMed 4207151
Immunochemical detection of the VkIV subgroup
3 (2), 219-22
DOI 10.1111/j.1365-3083.1974.tb01251.x, PubMed 4856661
Publications 1973
7S immunoglobulin M (IgM) from serum purified by anti-mu-chain immunoadsorbent: comparison of the reassociation properties of 7S IgM and various 19S IgM subunits
2 (5), 511-22
DOI 10.1111/j.1365-3083.1973.tb02057.x, PubMed 4204578
Immunoglobulins with special reference to cell-bound immunoglobulins
11 (2), 171-2
PubMed 4545243
Armauer Hansen--the man and his work
41 (4), 417-24
PubMed 4601451
[Scandinavian leprosy conference in Bergen. What do we know about leprosy and what do we do about it?]
88 (6), 186-9
PubMed 4778889
The N-terminal amino acid sequence of bovine pepsin (EC 3.4.4.1) and the sequence overlapping the activation fragment
34 (2), 311-4
DOI 10.1016/0014-5793(73)80819-1, PubMed 4583851
Rabbit anti rat lymphocyte serum: immunosuppression mediated by a pure IgM fraction
81 (5), 635-40
DOI 10.1111/j.1699-0463.1973.tb02254.x, PubMed 4209178
RABBIT ANTI RAT LYMPHOCYTE-SERUM - IMMUNOSUPPRESSION MEDIATED BY A PURE IGM FRACTION
ACTA PATH MICRO IM B, B 81 (5), 635-640
Publications 1972
[Nobel prize for immunoglobulin research]
92 (34), 2363-5
PubMed 4568120
[Leprosy]
92 (11), 793-4
PubMed 5028902
Oligoclonal macroglobulinaemia
1 (1), 13-26
DOI 10.1111/j.1365-3083.1972.tb03731.x, PubMed 4116376
Formation of hybrid IgM subunits
1 (1), 63-73
DOI 10.1111/j.1365-3083.1972.tb03736.x, PubMed 4627538
Reversible dissociation of reduced and alkylated IgM subunits to half subunits
9 (6), 623-34
DOI 10.1016/0019-2791(72)90248-0, PubMed 5041241
BINDING OF LIPID DYES TO IMMUNOGLOBULINS
Clin. Chim. Acta, 42 (2), 433-435
DOI 10.1016/0009-8981(72)90108-8
Publications 1971
[Immunological diagnosis in hematological diseases]
91 (23), 1655-8
PubMed 4938861
Cold auto-agglutinins
20 (4), 289-305
DOI 10.1111/j.1423-0410.1971.tb00447.x, PubMed 4942296
Quantitation of human serum immunoglobulins
28 (3), 241
PubMed 5135091
[Immunological diagnosis in hypergammaglobulinemia]
91 (23), 1641-7
PubMed 5110439
[Clinical immunology]
91 (23), 1623-7
PubMed 4938859
Family studies in individuals with selective absence of gamma-A-globulin
8 (2), 229-36
PubMed 4995563
Individual antigenic specificity of human macroglobulins. II. Dependence of an antigenic determinant on the disulfide bond between the and kappa chains
8 (10), 939-49
PubMed 4114318
Acute erythroleukaemia in a patient treated with melphalan for the cold agglutinin syndrome
8 (5), 375-9
DOI 10.1111/j.1600-0609.1971.tb00887.x, PubMed 5289695
[Acute erythroleukemia in a melphalan-treated patient with cold agglutination syndrome]
86 (49), 1494
PubMed 5289909
Experimental Arthus reactions using the same antigen in soluble and corpuscular form
2 (4), 319-28
PubMed 4255853
Publications 1970
Multiple M-components in a single individual. I. The structural relationship of two serum gamma M kappa M-components as revealed by combining specificity and individual antigenic specificity
7 (11), 899-915
PubMed 4099674
Publications 1969
[The year's Jahre Prize winners: Hans Bennich, Docent, M. D., and S. Gunnar O. Johansson, Docent, M. D., Academic Hospital, Uppsala]
89 (11), 840
PubMed 4183801
Individual antigenic specificity of human macroglobulins: Localization of antigenic determinants and their use to demonstrate formation of hybrid molecules after reduction and reassociation
129 (6), 1217-34
DOI 10.1084/jem.129.6.1217, PubMed 4977279
Protein abnormalities in the cold haemagglutinin syndrome
6 (6), 416-26
DOI 10.1111/j.1600-0609.1969.tb01836.x, PubMed 4984643
Chronic autoimmune hemolytic anemia in childhood with cold antibodies, aplastic crises, and familial occurrence
58 (3), 275-80
DOI 10.1111/j.1651-2227.1969.tb04717.x, PubMed 5783414
Publications 1967
Absorption and control of specificity of antisera
100, 9
PubMed 4166858
[Genes and immunology]
87 (5), Suppl:470-4
PubMed 4167292
Publications 1966
[Nomenclature of genetically determined characteristics of human immunoglobulins]
2 (3), 317-22
DOI 10.1007/BF00395948, PubMed 4168284
NOMENCLATURE OF GENETICALLY DETERMINED CHARACTERISTICS OF HUMAN IMMUNOGLOBULINS
HUMANGENETIK, 2 (3), 317
[We interview Erik Kåss, professor and physician at the Oslo Medical Society Rheumatism Hospital]
86 (6), 403-4
PubMed 5330298
Structural relationship between gamma-G- and gamma-M-globulin in man
445, 74-9
PubMed 4160695
Light chain types of transiently occurring cold haemagglutinins
3 (4), 269-76
DOI 10.1111/j.1600-0609.1966.tb02371.x, PubMed 4958443
Synthesis of donor type gamma-G-globulin following thymus transplantation in hypo-gamma-globulinaemia with severe lymphocytopenia
3 (5), 351-74
DOI 10.1111/j.1600-0609.1966.tb02379.x, PubMed 4163435
Heterogeneity of cold haemagglutinins
11 (4), 361-8
PubMed 5924621
Publications 1965
RHEUMATOID FACTOR--AUTOSPECIFICITY OR ISOSPECIFICITY?
10, 225-7
DOI 10.1111/j.1423-0410.1965.tb04344.x, PubMed 14339234
Pepsin-splitting of gamma-M-globulins and high molecular weight antibodies
17, Suppl 84:232+
PubMed 4159557
Reaction of I-131 trace labeled cold agglutinin
124 (2), 491-8
DOI 10.1111/j.1749-6632.1965.tb18983.x, PubMed 4953945
[NEW NOMENCLATURE FOR HUMAN IMMUNOGLOBULINS]
73, 108-9
PubMed 14252376
[HEAVY CHAIN DISEASE]
73, 640-1
PubMed 14299151
[INFERTILITY CAUSED BY IMMUNOLOGICAL FACTORS]
85, 308-9
PubMed 14305805
ANTIGENIC HETEROGENEITY OF WALDENSTROEM TYPE GAMMA-M-GLOBULINS
2, 137-47
PubMed 14341518
PROPERTIES OF VARIOUS ANTI-GAMMA-GLOBULIN FACTORS IN HUMAN SERA
121 (4), 503-19
DOI 10.1084/jem.121.4.503, PubMed 14276773
Exclusive occurrence of K chains in isolated cold haemagglutinins
2 (3), 259-66
DOI 10.1111/j.1600-0609.1965.tb01303.x, PubMed 4158055
Warm haemolysins active against trypsinized red cells; occurrence, inheritance, and clinical significance
23, 787-9
DOI 10.1159/000384368, PubMed 4956292
Publications 1964
STUDIES OF THE ANTIBODY NATURE OF THE RHEUMATOID FACTOR. REACTION OF THE RHEUMATOID FACTOR WITH SHEEP ERYTHROCYTES SENSITIZED WITH HUMAN ANTI-SHEEP CELL ANTIBODIES AND WITH O RH POSITIVE CELLS SENSITIZED WITH INCOMPLETE ANTI-RH ANTIBODIES
7 (4), 403-18
PubMed 14193154
[STRUCTURE AND FUNCTION OF THE GAMMA GLOBULINS]
84, 16-22
PubMed 14101792
[THYMUS: THE SUPREME IMMUNOLOGICAL ORGAN]
84, 46-51
PubMed 14101798
INTERACTIONS BETWEEN 131-I TRACE-LABELLED COLD AGGLUTININ, COMPLEMENT AND RED CELLS
10, 339-46
DOI 10.1111/j.1365-2141.1964.tb00710.x, PubMed 14179488
IMMUNOCHEMICAL PROPERTIES OF COLD HAEMAGGLUTININS
1, 223-37
DOI 10.1111/j.1600-0609.1964.tb00019.x, PubMed 14214902
Publications 1963
SPECIFICITY OF RHEUMATOID FACTOR FOR GENETIC TYPES OF HUMAN GAMMA BLOBULIN
6, SUPPL 427-45
DOI 10.1002/art.1780060419, PubMed 14056855
IDENTIFICATION OF THE COMPONENTS OF COMPLEMENT PARTICIPATING IN THE ANTIGLOBULIN REACTION
6 (4), 412-20
PubMed 14042906
Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies
8, 133-52
DOI 10.1111/j.1423-0410.1963.tb03290.x, PubMed 13940587
Publications 1962
Localization of two genetic factors to different areas of gamma-globulin molecules
136 (3520), 979-80
DOI 10.1126/science.136.3520.979, PubMed 14036038
Genetic characters of human gamma-globulins in myeloma proteins
116 (5), 719-38
DOI 10.1084/jem.116.5.719, PubMed 13952722
Publications 1961
Specificity of a rheumatoid factor
7, 13-7
DOI 10.3109/rhe1.1961.7.issue-1-4.02, PubMed 13711447
[The rheumatoid factor]
65, 216-7
PubMed 13711448
Interactions of rheumatoid factor with immune precipitate containing antibody of human origin
20 (4), 363-8
DOI 10.1136/ard.20.4.363, PubMed 13904576
Tanker om kronisk polyarthrit: foredrag holdt på Norske kvinners sanitetsforenings kretsmøte for Oslo og Aker i september 1960
Oslo, 16 s.
BIBSYS 061886440
Studies on the gamma globulin (Gm) serum groups
Oslo University press, Oslo, 1 b. (flere pag.)
BIBSYS 962298522
The application of the Gm system in paternity cases
6, 257-73
DOI 10.1111/j.1423-0410.1961.tb03162.x, PubMed 13711444
Studies on a serum with peculiar haemagglutinating properties
6, 409-28
DOI 10.1111/j.1423-0410.1961.tb03187.x, PubMed 13904575
Complement and complement components in acquired hemolytic anemia with high titer cold antibodies
170, 725-9
DOI 10.1111/j.0954-6820.1961.tb00291.x, PubMed 14452388
Publications 1960
Interactions between red cells coated with incomplete anti-D and rheumatoid sera
50, 383-97
DOI 10.1111/j.1699-0463.1960.tb01208.x, PubMed 13711445
Relation between Gm types and hemagglutinating substances in rheumatoid sera
50, 89-105
DOI 10.1111/j.1699-0463.1960.tb01175.x, PubMed 13711446
Publications 1959
A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry
11, 66-70
DOI 10.3109/00365515909060410, PubMed 13646603
A new haemagglutinating substance in the Gm system, anti-Gm
183 (4673), 1468-9
DOI 10.1038/1831468a0, PubMed 13657175
Quantitative studies on the hemagglutination inhibition reaction for determination of the Gm types
47, 199-208
DOI 10.1111/j.1699-0463.1959.tb04849.x, PubMed 14399692
A new hemagglutinating substance in the Gm system, anti-Gmb
47, 191-8
DOI 10.1111/j.1699-0463.1959.tb04848.x, PubMed 14399693
A new type in the Gm system
45 (4), 357-70
DOI 10.1111/j.1699-0463.1959.tb04721.x, PubMed 13660835
Publications 1957
Lactic acid content in human venous blood during hypoxia at high altitude
40 (2-3), 248-53
DOI 10.1111/j.1748-1716.1957.tb01494.x, PubMed 13469531
The influence of methemoglobin and storage upon the spectrophotometric determination of carbon monoxide in blood
9 (4), 317-21
PubMed 13495356
Ventilatory studies of the lungs during continuous pressure breathing
41 (1), 77-89
DOI 10.1111/j.1748-1716.1957.tb01511.x, PubMed 13497760